HOMA-IR z-scores were associated with increased risks for incident lung disease, interstitial lung abnormalities, and ...

Tuberculosis remains a public health crisis. The World Health Organization's Global Tuberculosis Report released in November ...

Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – tiakis ...

The phase III A DUE trial showed significantly greater pulmonary vascular resistance improvements with the fixed-dose ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling of the precapillary pulmonary arteries, with excessive proliferation of vascular cells. Although the exact ...

Abu Dhabi (DoH)—has granted early access to a groundbreaking medication for patients with pulmonary arterial hypertension, ...